TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 2 | -2 | 3 | -9 | -18 | -41 | -11 |
| S | %wins | 50 | 100 | 50 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/14/06 20:39 | 12/13/06 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Negro-Vilar Andres | CA | O | Exe V-P, | S.dm | -129 | 11.05 | 1 | -12 | -62 | 7 | D | -12 | -3 | 10 | 9 | 1 | -3 | 1 | 2 | -1 | -3 | 0 | -10 | -19 | -43 |
12/13/06 16:47 | 12/11/06 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Negro-Vilar Andres | CA | O | Exe V-P, | S.d | -323 | 10.76 | 1 | -30 | -81 | 7 | D | -12 | -4 | 9 | 6 | -2 | -4 | 0 | 1 | 4 | 0 | 6 | -8 | -17 | -38 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |